Get Fit Bharat

Tag: Endurance

HomeEndurance

October 31, 2024 – Biosergen AB (“Biosergen”), a clinical-stage biotechnology company developing therapies for life-threatening fungal diseases, today announced the completion of treatment for the first cohort of patients in its proof-of-concept clinical trial for its antifungal drug-candidate BSG005. The cohort consisted of five patients: two completely recovered, two saw …

FIDELITY JAPAN TRUST PLC (the 'Company')     TRANSACTION IN OWN SHARES     The Board of the Company announces that it has bought into Treasury     Number of shares repurchased: 23,350 Date of transaction: 31 October 2024 Average share price paid per share (GBp): 154.030 Lowest share price paid per share (GBp): 154.000 …

Atomic Ambitions Expansion Adds Nuclear Power and More STOCKHOLM - 31 October 2024 - The secrets of radioactivity unlock new strategic and development options in Atomic Ambitions, a new expansion for Millennia, the historical 4X strategy game from C Prompt Studios and Paradox Interactive. Power your empire with nuclear plants, …

Stockholm, Sweden November 1, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: Leqembi) subcutaneous autoinjector for weekly maintenance dosing after …